Oxford University's Medical Sciences Division is an internationally recognised centre of excellence for biomedical and clinical research and teaching, comprised of 16 core departments and the School of Medicine and Biomedical Sciences. www.medsci.ox.ac.uk
Oxford Medical Sciences Division
We have some new activities in our wellbeing areas: mini jigsaws and Rubik's cubes!! So if you need to take your mind off your work or studies for a while, pop in and get puzzling or twisting!
@ouhospitals.bsky.social
@medsci.ox.ac.uk
Newborn meningitis is one of the most dangerous childhood infections.
@mucosalimmunology.bsky.social & colleagues developed an approach that stops harmful bacteria before transmission, combining an oral vaccine, harmless competitor bacteria, and bacteriophages.
www.path.ox.ac.uk/news-article...
TRAINING: Applications to the Oxford Winter Neuroethics School (OWNS) 2026 are open
A course for students, postgraduates and early-career professionals exploring research in the ethics of neuroscience, psychiatry and mental health.
Apply by Tue 30 June
https://www.owns.org.uk/
The human #heart is a biological powerhouse that has the capacity to beat billions of times. But what prompts that very first #heartbeat? And how can #ComputationalArt help us to unravel the mystery? @clcortex.bsky.social explains in our brand new video.
🎥 https://bit.ly/HeartsAnewÂ
1/2
Emma Slack and collaborators have developed a preventive approach that stops harmful bacteria in their tracks before transmission even occurs.
NEW: Scientists have solved a decades-old mystery behind inflammatory bowel disease (IBD).
The team uncovered how a known genetic risk factor drives harmful inflammation - a discovery that could help pave the way for faster diagnosis and more targeted treatments.
https://bit.ly/4eghPGm
Video
NEWS: Exosomes are more diverse than we previously thought: implications for disease diagnosis and management
Read the opinion article 👇
EVENT: 13th SRUK/CERU International Symposium
📢Registration closes today!
The symposium will bring together researchers and professionals to explore how collaboration drives innovation. @kavlioxford.bsky.socialÂ
26–28 June
https://events.ox.ac.uk/oxford_event/0415b964-db59-f111-a825-6045bdcfe41f
NEWS: Pioneering study sets out to answer and address why osteoarthritis impacts patients differently
Read about @ndorms.bsky.social participation in the SOLVE research consortium.
NEWS: First trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford
Read about the Phase 1 of the INTERCEPT-Lynch trial 👇
EVENT: AI is transforming global health. But whose data does it rely on & whose interests does it serve?
Join the launch of the #OxfordGlobalHealth Seminar Series with Profs Tingting Zhu & Angeliki Kerasidou.Â
Fri 12 June
https://events.ox.ac.uk/oxford_event/deafce22-ba4a-f111-bec7-7c1e52046306
Bodleian Health Care Libraries
The Dunn School, Oxford
Oxford Medical Sciences Division
A new opinion article published in Trends in Cell Biology explores how tiny packages released by cells, known as exosomes, could help researchers better understand disease and may one day support new approaches to diagnosis and treatment.
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) are playing leading roles in a major new UK-wide research consortium aiming to improve treatment and outcomes for people living with osteoarthritis.
www.medsci.ox.ac.uk
Oxford Medical Sciences Division
Oxford Medical Sciences Division
Oxford Medical Sciences Division
Oxford Medical Sciences Division
Oxford Medical Sciences Division
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.
